全文获取类型
收费全文 | 32725篇 |
免费 | 3956篇 |
国内免费 | 585篇 |
专业分类
耳鼻咽喉 | 533篇 |
儿科学 | 591篇 |
妇产科学 | 525篇 |
基础医学 | 6354篇 |
口腔科学 | 624篇 |
临床医学 | 1962篇 |
内科学 | 5384篇 |
皮肤病学 | 560篇 |
神经病学 | 4961篇 |
特种医学 | 602篇 |
外国民族医学 | 4篇 |
外科学 | 2732篇 |
综合类 | 2182篇 |
现状与发展 | 2篇 |
预防医学 | 1144篇 |
眼科学 | 206篇 |
药学 | 4712篇 |
4篇 | |
中国医学 | 579篇 |
肿瘤学 | 3605篇 |
出版年
2024年 | 25篇 |
2023年 | 140篇 |
2022年 | 1299篇 |
2021年 | 1841篇 |
2020年 | 875篇 |
2019年 | 1029篇 |
2018年 | 1038篇 |
2017年 | 1269篇 |
2016年 | 1213篇 |
2015年 | 1914篇 |
2014年 | 1954篇 |
2013年 | 1704篇 |
2012年 | 1882篇 |
2011年 | 1969篇 |
2010年 | 1788篇 |
2009年 | 1504篇 |
2008年 | 1697篇 |
2007年 | 1188篇 |
2006年 | 1116篇 |
2005年 | 1100篇 |
2004年 | 964篇 |
2003年 | 942篇 |
2002年 | 774篇 |
2001年 | 705篇 |
2000年 | 576篇 |
1999年 | 588篇 |
1998年 | 702篇 |
1997年 | 656篇 |
1996年 | 509篇 |
1995年 | 440篇 |
1994年 | 416篇 |
1993年 | 443篇 |
1992年 | 305篇 |
1991年 | 267篇 |
1990年 | 237篇 |
1989年 | 182篇 |
1988年 | 207篇 |
1987年 | 205篇 |
1986年 | 283篇 |
1985年 | 247篇 |
1984年 | 206篇 |
1983年 | 174篇 |
1982年 | 165篇 |
1981年 | 158篇 |
1980年 | 118篇 |
1979年 | 68篇 |
1978年 | 45篇 |
1977年 | 34篇 |
1976年 | 28篇 |
1975年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Detection of cytoplasmic IL-1 beta in peripheral blood mononuclear cells from intensive care unit (ICU) patients. 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Clinical and experimental immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Cytokines including IL-1 beta have been implicated in the pathophysiology of sepsis and the systemic inflammatory response. It is believed that certain critically ill patients may be 'primed' with respect to cytokine production, and that subsequent 'triggers' may cause exaggerated cytokine production in these patients with exacerbation of their clinical condition; however, no means of identifying 'primed' patients has been described. The presence of cytoplasmic IL-1 beta within peripheral blood mononuclear cells (PBMC) from patients in the ICU was investigated as a means of identifying 'primed' patients, using fluorescent antibody labelling and flow cytometry. The study revealed that PBMC from ICU patients had a different staining pattern for IL-1 beta than those from healthy subjects, and that PBMC from certain ICU patients did indeed stain strongly for IL-1 beta; however, the presence of these strongly staining cells was not associated with clinical condition or outcome. It is concluded that whilst it might be possible to identify 'primed' patients in the ICU using this technique, this is of no clinical value as a predictor of clinical course. 相似文献
53.
Abstract: We analyzed the expression of CEA, CA19-9, CA125, CA15-3 (DF3), PCNA and p53 immunohistochemically in 14 tissue specimens of mucosal cancers in adenoma, seven tubulovillous adenoma specimens, and 16 tubular adenoma specimens. The rates of positive staining for mucosal cancer in adenoma, tubulovillous adenoma and tubular adenoma specimens, respectively, were: for CEA: 100%, 85.7% and 75%; for CA19-9: 71.4%, 71.4% and 56.2%; for CA125:0%, 0% and 0%;for CA15-3 (DF3): 64.3 %, 0% and 0 %; for PCNA: 100%, 88.9% and 56.2%; and for p53: 35.7%, 0% and 0% . The results suggest that the expressions of CEA, CA19-9, CA15-3 (DF3), PCNA and p53 are related to colorectal tumorigenesis. None of the specimens studied showed staining for CA125, suggesting that CA125 is not involved in the early stages of colorectal carcinogenesis. There was no significant difference in the rates of positive staining for CEA and CA19-9 among mucosal cancer in adenoma, tubular adenoma and tubulovillous adenoma specimens. However, the rates of positive staining for PCNA and p53 were significantly higher in mucosal cancer in adenoma specimens than for tubular adenoma specimens (p<0.05), and the rate of CA15-3 (DF3) positive staining was significantly higher for mucosal cancer in adenoma than for tubulovillous adenoma (p<0.01) and tubular adenoma (p< 0.001) specimens. Therefore, the CA15-3 (DF3) antigen is an immunohistochemical marker for colorectal carcinomas. The present results suggest that CA15-3 (DF3), PCNA and p53 play important roles in the genesis of colorectal adenomas. 相似文献
54.
Rolf W. Hartmann Martin Frotscher Dorothea Ledergerber Gerald A. Wchter Gertrud L. Grün Tom F. Sergejew 《Archiv der Pharmazie》1996,329(5):251-261
In search of potential drugs for the treatment of estrogen- and androgen-dependent cancer as well as the prophylaxis of metastases, tetralones, tetralins, and dihydronaphthalenes bearing a OCH3 substituent at the benzene nucleus and an imidazol-4-yl, imidazol-1-yl, or 1,2,4-triazol-1-yl substituent in 2-position were synthesized with and without C1-spacer between the rings (compounds 2 – 26 ). The compounds were tested in vitro for inhibition of the three target enzymes P450 arom (human placental microsomes), P450 17 (rat testicular microsomes), and P450 TxA2 (citrated human whole blood). To examine selectivity, some compounds were further tested in vitro for inhibition of P450 18 (bovine adrenal mitochondria), P450 see (bovine adrenal mitochondria) and corticoid formation (aldosterone, corticosterone; ACTH stimulated rat adrenal tissue). In vivo, selected compounds were examined in Sprague Dawley rats regarding P450 TxA2 inhibition, reduction of plasma testosterone concentration, antiuterotrophic activity (inhibition of the uterotrophic activity of androstenedione), reduction of plasma estradiol concentration (pregnant mares' serum gonadotropin-primed rats), and mammary tumor inhibiting activity (dimethylbenzanthracene-induced tumor; pre- and postmenopausal model). In the series of imidazol-4-yl compounds, which represent a novelty in the field of azole inhibitors of steroidogenic P450 enzymes, strong inhibitors of P450 arom and/or P450 17 were found: 7-OCH3-2-(imidazol-4-ylmethylene)-1-tetralone ( 4 ) and 7-OCH3-2-(imidazol-4-ylmethyl)-tetralin ( 12 ) are among the most potent inhibitors of P450 arom in vitro known so far. Compound 4 is a selective inhibitor, whereas 12 shows in addition strong inhibition of P450 17. In contrast to 12 , the 6-OCH3 derivative (compound 11 ) is a selective inhibitor of P450 17, being 50 times more potent than ketoconazole. Some imidazol-1-yl compounds show a marked inhibition of P450 TxA2: 2-(imidazol-1-ylmethyl)-1-tetralone ( 13 ) is a selective inhibitor of P450 TxA2, whereas 7-OCH3-2-(imidazol-1-ylmethyl)-tetralin ( 17 ) as well as 2-(imidazol-1-ylmethyl)-tetralin ( 16 ) and 7-OCH3-2-imidazol-1-yl-3,4-dihydronaphthalene ( 25 ) additionally show strong inhibition of P450 arom and P450 17. Regarding the other steroidogenic P450 enzymes as well as corticosterone formation, the compounds show only little inhibitory activity. Aldosterone formation, however, is inhibited at low concentrations. Nevertheless, 4 and 12 are more selective, i.e. inhibit aldosterone synthesis less than the well known inhibitor of P450 arom fadrozole. The compounds show activity in the aforementioned in vivo tests. 相似文献
55.
对雄性Wisiaf大鼠腹腔1次注射碘-13l, 注入活度分别为0.59×104Bq,2.37×104Bq, 4.34×104Bq, 8.23×104Bq, 碘-125注入活度分别为3.7×104Bq, 7.4×104Bq, 14.8×104Bq, 22.2×104Bq.碘-131诱发肿痛实际注入活度在2.37×104Bq以下,碘-125的为7.4×104以下.诱发的肿瘤以甲状腺肿瘤为主,其次为垂体肿瘤. 相似文献
56.
标记抗原在贮存过程中,由于受幅射分解和脱碘影响而使免疫活性和生物活性降低。我们对自制的~(125)碘-绒毛膜促性腺激素进行了实验观察。结果显示:贮存1月后,其免疫活性和生物活性分别降低了33.1%和44.0%;经电泳纯化后的标记物的免疫活性和生物活性明显提高,分别达到了最初的90.5%和95.3%。 相似文献
57.
J. B. Payne R. A. Reinhardt M. P. Masada L. M. DuBois A. C. Allison 《Journal of periodontal research》1993,28(6):451-453
Gingival crevicular fluid (GCF) IL-8 and IL-1,1β levels were determined by sandwich enzyme-linked immunosorbent assays. Associations between IL-8 and IL-1β GCF levels, and between these cytokines and patient estrogen status were evaluated. IL-8 and IL-1β were detected more frequently and in higher amounts/30 s GCF sample in estrogen-deficient patients than in estrogensufficient patients. IL-8 and IL-1β GCF levels were significantly correlated. These lindings suggest that GCF IL-8 levels are associated with patient estrogen status and local IL-1β concentrations. 相似文献
58.
Jalil Tavakkol AFSHARI Zahra REZAIEYAZDI Farnaz SHOJA‐TAHERI Majid SADEGHIZADEH 《International journal of rheumatic diseases》2007,10(3):209-213
Aim: Rheumatoid arthritis (RA) is the most common chronic inflammatory erosive joint disease with the worldwide distribution of approximately 0.5–1.0%. Etiology of RA is not exactly known but immunologic and genetic factors play an important role in the pathogenesis of the disease. Genetic factors such as human leukocyte antigens (HLA) are responsible for many autoimmune diseases; therefore we decided to look for a correlation between RA and the presence of HLA‐DQβ1 alleles as possible genetic markers. Methods: Genomic DNA from the whole blood samples of 25 patients with RA and 86 normal individuals as control group were extracted by salting out method. The genomic DNA was amplified by polymerase chain reaction‐sequence specific primer (PCR‐SSP) technique. HLA‐typing was done by this method after optimizing the PCR reaction for each allele. In this procedure seven serological subclasses of HLA‐DQβ1 can be detected. Results: Comparing the results between the patients and controls show a significant increase in the frequency of HLA‐DQ8 (*0302, *0305) alleles in RA patients. The P‐values were 0.007 and the relative risk for these alleles was evaluated higher than 1. Conclusions: The results suggest that DQ8 is the dominant HLA‐DQβ1 allele that is associated with susceptibility to RA in north‐eastern Iran. 相似文献
59.
目的探讨CD11b在肺纤维化患者外周血中性粒细胞上的表达及红霉素对它的影响.方法肺纤维化患者(A组,n=13)13例经红霉素治疗3个月,收集治疗前后及健康对照组(B组,n=13)13例的外周血中性粒细胞涂片,用桥联酶免疫法测定CD11b表达阳性的中性粒细胞百分率.结果A组治疗前后,患者外周血中性粒细胞CD11b的表达阳性率均显著高于健康对照组(P<0.01);A组治疗前,患者外周血中性粒细胞CD11b的表达阳性率显著高于治疗后(P<0.01).结论肺纤维化患者外周血中性粒细胞CD11b的表达阳性率显著高于健康对照组;红霉素能抑制肺纤维化患者外用血中性粒细胞CD11b的表达. 相似文献
60.
SK&F 86466, 6-chloro-3-methyl-2,3,4,5-tetrahydro-1-H-3-benzazepine, is a potent and selective antagonist of the α2-adrenoceptor in vitro. This compound produced a small pressor response accompanied by a marked bradycardia when administered i.v. to the pithed normotensive rat. The pressor response was not affected by reserpine treatment, pretreatment with α- or β-adrenoceptor antagonists, atropine, or hexamethonium. The bradycardia was markedly reduced by bilateral vagotomy and pretreatment with atropine and attenuated by hexamethonium. The negative chronotropic action of SK&F 86466 was abolished by a combination of vagotomy and atropine. Mediation of the bradycardia by a baroreceptor reflex was ruled out by the observations that a lack of change in heart rate was associated with the vasopressor response to phenylephrine in the pithed rat pretreated with propranolol. It is concluded that the negative chronotropic action of SK&F 86466 in the pithed rat is mediated indirectly by activation of the cholinergic innervation of the heart. 相似文献